Gary A. Rogers

2.6k total citations
46 papers, 2.2k citations indexed

About

Gary A. Rogers is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Gary A. Rogers has authored 46 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cellular and Molecular Neuroscience, 28 papers in Molecular Biology and 10 papers in Cognitive Neuroscience. Recurrent topics in Gary A. Rogers's work include Neuroscience and Neuropharmacology Research (35 papers), Receptor Mechanisms and Signaling (14 papers) and Memory and Neural Mechanisms (8 papers). Gary A. Rogers is often cited by papers focused on Neuroscience and Neuropharmacology Research (35 papers), Receptor Mechanisms and Signaling (14 papers) and Memory and Neural Mechanisms (8 papers). Gary A. Rogers collaborates with scholars based in United States, Sweden and Switzerland. Gary A. Rogers's co-authors include Gary Lynch, Markus Kessler, Sam A. Deadwyler, Stanley M. Parsons, Amy Arai, Robert E. Hampson, Thomas C. Bruice, Ben A. Bahr, Mike Davis and Richard Granger and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Neuroscience and Biochemistry.

In The Last Decade

Gary A. Rogers

46 papers receiving 2.1k citations

Peers

Countries citing papers authored by Gary A. Rogers

Since Specialization

Citations

This map shows the geographic impact of Gary A. Rogers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary A. Rogers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary A. Rogers more than expected).

Fields of papers citing papers by Gary A. Rogers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary A. Rogers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary A. Rogers. The network helps show where Gary A. Rogers may publish in the future.

Co-authorship network of co-authors of Gary A. Rogers

This figure shows the co-authorship network connecting the top 25 collaborators of Gary A. Rogers. A scholar is included among the top collaborators of Gary A. Rogers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary A. Rogers. Gary A. Rogers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ampakines Attenuate Staurosporine-induced Cell Death in Primary Cortical Neurons: Implications in the ‘Chemo-Brain’ Phenomenon 2018 ·Anticancer Research ·Daniel P. Radin, Gary A. Rogers, Kimberley E. Hewitt, (unknown), Arnold Lippa	8
2	Stargazin differentially modulates ampakine gating kinetics and pharmacology 2018 ·Biochemical Pharmacology ·Daniel P. Radin, Yongxin Li, Gary A. Rogers, (unknown), Arnold Lippa	4
3	Substituted benzoxazinones as potent positive allosteric AMPA receptor modulators: Part II 2011 ·Bioorganic & Medicinal Chemistry Letters ·Rudolf Mueller, Stanisław Rachwał, (unknown), Yong‐Xin Li, Sheng Zhong, Aidan J. Hampson, J. Ułas, Mark A. Varney, (unknown), Gary A. Rogers	21
4	Benzoxazinones as potent positive allosteric AMPA receptor modulators: Part I 2011 ·Bioorganic & Medicinal Chemistry Letters ·Rudolf Mueller, Yong‐Xin Li, Aidan J. Hampson, Sheng Zhong, (unknown), (unknown), Stanisław Rachwał, J. Ułas, (unknown), Gary A. Rogers	32
5	Facilitation of Task Performance and Removal of the Effects of Sleep Deprivation by an Ampakine (CX717) in Nonhuman Primates 2005 ·PLoS Biology ·Linda J. Porrino, James B. Daunais, Gary A. Rogers, Robert E. Hampson, Sam A. Deadwyler	128
6	Benzamide-Type AMPA Receptor Modulators Form Two Subfamilies with Distinct Modes of Action 2002 ·Journal of Pharmacology and Experimental Therapeutics ·Amy Arai, Yanfang Xia, Gary A. Rogers, Gary Lynch, Markus Kessler	93
7	Effects of the Potent Ampakine CX614 on Hippocampal and Recombinant AMPA Receptors: Interactions with Cyclothiazide and GYKI 52466 2000 ·Molecular Pharmacology ·Amy Arai, Markus Kessler, Gary A. Rogers, Gary Lynch	113
8	The norbornenyl moiety of cyclothiazide determines the preference for flip-flop variants of AMPA receptor subunits 2000 ·Neuroscience Letters ·Markus Kessler, Gary A. Rogers, Amy Arai	17
9	Synergistic Interactions between Ampakines and Antipsychotic Drugs 1999 ·Journal of Pharmacology and Experimental Therapeutics ·Steve A. Johnson, N. Thin Luu, (unknown), Richard J. Knapp, David Lutz, Amy Arai, Gary A. Rogers, Gary Lynch	66
10	Enhancement by an Ampakine of Memory Encoding in Humans 1997 ·Experimental Neurology ·Martin Ingvar, José Ambros‐Ingerson, Mike Davis, Richard Granger, Markus Kessler, Gary A. Rogers, Robert S. Schehr, Gary Lynch	176
11	Effects of an AMPA receptor modulator on methamphetamine-induced hyperactivity in rats 1996 ·Brain Research ·John Larson, (unknown), (unknown), (unknown), Gary A. Rogers, Gary Lynch	37
12	Facilitation of glutamate receptors reverses an age-associated memory impairment in rats 1996 ·Synapse ·Richard Granger, Sam A. Deadwyler, Mike Davis, (unknown), Markus Kessler, Gary A. Rogers, Gary Lynch	83
13	Enhanced glutamatergic neurotransmission facilitates classical conditioning in the freely moving rat 1995 ·Neuroscience Letters ·Tracey J. Shors, Richard J. Servatius, Richard F. Thompson, Gary A. Rogers, Gary Lynch	42
14	A centrally active drug that modulates AMPA receptor gated currents 1994 ·Brain Research ·Amy Arai, Markus Kessler, Peng Xiao, José Ambros‐Ingerson, Gary A. Rogers, Gary Lynch	107
15	18F-labelled vesamicol derivatives: Syntheses and preliminary in vivo small animal positron emission tomography evaluation 1994 ·Nuclear Medicine and Biology ·Gary A. Rogers, Sharon Stone‐Elander, Martin Ingvar, Lars I. Eriksson, Stanley M. Parsons, L. Widén	24
16	Chapter 20: Acetylcholine transporter — vesamicol receptor pharmacology and structure 1993 ·Progress in brain research ·Stanley M. Parsons, Ben A. Bahr, Gary A. Rogers, Edward D. Clarkson, (unknown), (unknown)	21
17	Photoaffinity labeling of the acetylcholine transporter 1992 ·Biochemistry ·Gary A. Rogers, Stanley M. Parsons	12
18	Linkage of the acetylcholine transporter-vesamicol receptor to proteoglycan synaptic vesicles 1992 ·Biochemistry ·Ben A. Bahr, (unknown), Gary A. Rogers, (unknown), Stanley M. Parsons	20
19	Purification and Characterization of a Nonvesicular Vesamicol‐Binding Protein from Electric Organ and Demonstration of a Related Protein in Mammalian Brain 1991 ·Journal of Neurochemistry ·(unknown), Gary A. Rogers, Stanley M. Parsons	25
20	Synthesis, in vitro acetylcholine-storage-blocking activities, and biological properties of derivatives and analogs of trans-2-(4-phenylpiperidino)cyclohexanol (vesamicol) 1989 ·Journal of Medicinal Chemistry ·Gary A. Rogers, Stanley M. Parsons, D. C. Anderson, Lena Nilsson, Ben A. Bahr, Wayne D. Kornreich, (unknown), Robert S. Jacobs, Bernard Kirtman	211

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact